![Imidazo[1,2-B][1,2,4]triazine derivatives as antiparasitic agents](/docs/US/2018-09-04/US10065965B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[1,2-B][1,2,4]triazine derivatives as antiparasitic agents
-
Application No.: US15575032Application Date: 2016-05-26
-
Publication No.: US10065965B2Publication Date: 2018-09-04
- Inventor: Stephen Brand , Elisabet Viayna Gaza , Ian Gilbert , Eun Jung Ko , Maria Marco Martin , Timothy James Miles , Lars Henrik Sandberg , Michael George Thomas
- Applicant: GlaxoSmithKline Intellectual Property Development Limited , The University of Dundee
- Applicant Address: GB Brentford, Middlesex GB Dundee
- Assignee: GlaxoSmithKline Intellectual Property Development Limited,The University of Dundee
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited,The University of Dundee
- Current Assignee Address: GB Brentford, Middlesex GB Dundee
- Agent Nicole Ginanni; Andrea V. Lockenour
- Priority: EP15382283 20150529
- International Application: PCT/EP2016/061887 WO 20160526
- International Announcement: WO2016/193111 WO 20161208
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/53 ; A61P33/02 ; A61K45/06 ; A61K31/5377
![Imidazo[1,2-B][1,2,4]triazine derivatives as antiparasitic agents](/abs-image/US/2018/09/04/US10065965B2/abs.jpg.150x150.jpg)
Abstract:
A compound of Formula (I), or a salt thereof, compositions comprising the compound, processes for its preparation and its use in therapy, for example in the treatment of parasitic diseases such as Chagas disease, Human African Trypanosomiasis (HAT) and leishmaniasis, particularly visceral leishmaniasis (VL).
Public/Granted literature
- US20180141949A1 IMIDAZO[1,2-B][1,2,4]TRIAZINE DERIVATIVES AS ANTIPARASITIC AGENTS Public/Granted day:2018-05-24
Information query
